SCHEMBL23112307

SCHEMBL23112307

CCOC(=O)c1n[nH]c(C(=O)OCC)c1C(F)F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
KDM4E B2RXH2 5/20 0.46
POLB P06746 2/20 0.44
HSD17B10 Q99714 2/20 0.43
PDE4D Q08499 1/20 0.42
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HPGD P15428 3/20 0.39
ALDH1A1 P00352 2/20 0.39
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39
LMNA P02545 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
ALOX15 P16050 1/20 0.37
AURKA O14965 1/20 0.36
MAPK10 P53779 1/20 0.36
RIPK1 Q13546 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7254577 0.86 MAPT (0.49) MAPTKDM4EPOLBHSD17B10PDE4D
SCHEMBL24906486 0.79 HSD17B10 (0.39) MAPTKDM4EPOLBHSD17B10PDE4D
SCHEMBL10860621 0.78 KDM4E (0.51) MAPTKDM4EPOLBHSD17B10PDE4D
SCHEMBL9941259 0.77 KDM4E (0.50) MAPTKDM4EPOLBHSD17B10PDE4D
SCHEMBL7254411 0.77 MAPT (0.63) MAPTKDM4EPOLBHSD17B10PDE4D
SCHEMBL10861249 0.77 PDE4D (0.56) MAPTKDM4EPOLBHSD17B10PDE4D
SCHEMBL19253412 0.76 MAPT (0.55) MAPTKDM4EPOLBHSD17B10PDE4D
SCHEMBL1456428 0.76 KDM4E (0.49) MAPTKDM4EPOLBHSD17B10PDE4D
SCHEMBL15564064 0.75 KDM4E (0.46) MAPTKDM4EPOLBHSD17B10PDE4D
SCHEMBL23112395 0.74 KDM4E (0.48) MAPTKDM4EPOLBHSD17B10PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220324865-A1 SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2022-10-13 US disclosed
EP-3793559-A1 SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES Bayer Aktiengesellschaft (DE) 2021-03-24 EP disclosed
CN-112469412-A Substituted dihydropyrazolopyrazine carboxamide derivatives 拜耳公司 2021-03-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220324865-A1 SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES QDPR, SIRT5, PDXK MAPT 3520/4885KDM4E 2278/4885POLB 3110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.